Michael Rome
InvestorManaging Director at Foresite Capital
Los Angeles, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Michael
98 people in our graph can introduce you to Michael.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Victoria Lewis to introduce you to Michael
You →Victoria · together at Foresite Capital (2022–2025) →Michael
Ask Jamie Chen to introduce you to Michael
You →Jamie · 11 people · together at Foresite Capital →Michael
Sign up to find every way you can get introduced to Michael
- Your email: the people you already email who know Michael
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Michael
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Experience
- Foresite CapitalManaging Directorcurrent2016 — present
- DAFNA Capital Management, LLCAnalyst2015 — 2016Los Angeles
- Vault PharmaScientist and Senior Scientist2014 — 2015Greater Los Angeles Area
- University of California, Los AngelesLab Assistant and Researcher2003 — 2006UCLA
Skills & more
From Michael's professional profile.
Deals · 3
Fl2021-001Board seat
via Foresite Capital · filed Mar 2021 · $60M raise
Theseus PharmaceuticalsBoard seat
via Foresite Capital · filed Feb 2021 · $22.1M raise
Kinnate BiopharmaBoard seat
via Foresite Capital · filed Dec 2019 · $74.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Sources: SEC Form D filings · curated public sources.
Colleagues at Foresite Capital
Network1
Investors connected to Michael in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Michael Rome?
- Managing Director at Foresite Capital
- Where does Michael Rome work?
- Michael Rome is Managing Director at Foresite Capital.
- What check size does Michael Rome write?
- Michael Rome typically writes checks of $100K – $5M.
- What boards does Michael Rome sit on?
- Michael Rome holds tracked board seats at Fl2021-001, Kinnate Biopharma, Remix Therapeutics, Theseus Pharmaceuticals.
- What companies has Michael Rome invested in?
- Investments tracked here include Alumis, CG Oncology, Khartis Therapeutics, Kinnate Biopharma, Nurix Therapeutics, RayThera, Remix Therapeutics, Theseus Pharmaceuticals, Xinthera.
- Where did Michael Rome go to school?
- Michael Rome studied at Caltech (Doctor of Philosophy (Ph.D.), Biochemistry); UCLA (BS, Molecular).
Same school
Also attended Caltech287
+ 281 more
Also attended UCLA1,017
+ 1,011 more
Shared employers
Also worked at DAFNA Capital Management, LLC1
Also worked at Vault Pharma1
Also worked at University of California, Los Angeles166
+ 160 more






























